1. Home
  2. KWR vs CLDX Comparison

KWR vs CLDX Comparison

Compare KWR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quaker Houghton

KWR

Quaker Houghton

HOLD

Current Price

$119.92

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$28.47

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KWR
CLDX
Founded
1918
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
KWR
CLDX
Price
$119.92
$28.47
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$152.50
$44.50
AVG Volume (30 Days)
158.7K
857.8K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
1.69%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,888,634,000.00
$12,743,000.00
Revenue This Year
$5.05
$97.61
Revenue Next Year
$4.03
$252.01
P/E Ratio
N/A
N/A
Revenue Growth
2.66
87.78
52 Week Low
$95.91
$14.40
52 Week High
$183.01
$31.85

Technical Indicators

Market Signals
Indicator
KWR
CLDX
Relative Strength Index (RSI) 23.40 51.12
Support Level $111.56 $24.70
Resistance Level $126.57 $30.90
Average True Range (ATR) 5.23 1.22
MACD -2.21 -0.14
Stochastic Oscillator 10.03 1.88

Price Performance

Historical Comparison
KWR
CLDX

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: